The first prime editing clinical trial has been cleared by @US_FDA to begin: prime editing of HSCs to treat chronic granulomatous disease (CGD). Congratulations to @PrimeMedicine on achieving this key milestone only 4.5 years after we published the first prime editing paper.

On 24 April 2024, the UK Takeover Panel released a Public Consultation Paper, outlining its proposals for a revised jurisdictional framework which would narrow the scope of application of the Takeover Code. www.edwincoe.com/blo… #corporatelaw #corporate #takeover

1/@PrimeMedicine today announced that the @US_FDA has cleared its Investigational New Drug (IND) application for PM359 for the treatment of chronic granulomatous disease-CGD, thus enabling $PRME to initiate its first Prime Editing global Phase 1/2 clinical trial in the US. $XBI

To help users study or prepare for exams this term we've put together: A display of study skills books. 2 flashcard creation stations. A whiteboard for tips for breaks and treats. Increased signage for our past papers and scrap paper. Recommended apps for study and relaxation.

Read this morning's papers from the UK and around the world with #PressReader and #Libby on your PC, tablet or smartphone. For more info buff.ly/481WAUo or click on the "Extras" section on the Libby app. pic.twitter.com/iFJg…

Results of our first @SmartFamily_KIT trial published! In the paper led by @KathrinWunsch and me, we found no evidence for the effectiveness of collaborative goal setting for PA in a family-based #mhealth application. Main limitation: active sample mhealth.jmir.org/202…

Only 2 days left on our SPECIAL EASTER OFFER! Enjoy Full access to your favourite newspaper this month with The Standard E-Paper App! Download and stay updated at 30% DISCOUNT Yearly for just Sh5300! To subscribe, visit shorturl.at/elmGY today.

🔥 Read our Highly Cited Paper 📚 Research on Artificial Intelligence in New Year Prints: The Application of the Generated Pop Art Style Images on Cultural and Creative Products 🔗 www.mdpi.com/2076-34… 👨‍🔬 by Mr. Bolun Zhang and Dr.Nurul Hanim Romainoor #culturalheritage pic.twitter.com/0van…

Our paper published: "Semi-supervised learning towards automated #segmentation of #PET images with limited annotations: application to #lymphoma" Great efforts led by @FereshtehRizi Semi-supervised framework holds great promise to tackle challenges with supervised learning

Can anyone explain why we have this deposit return scheme and there's no way of getting the money onto an app like Apple Pay or Google Pay? Little slips of paper that I end up forgetting to use at the till.

Exciting news! We're simplifying bus travel with our app's new single and return tickets on services 22, 23, and 28. Ditch the paper and spare change – hop on the digital drive today and #TapTheApp: stge.co/44lt0rZ

En route to Barcelona for a meeting with collaborators and brainstorming session on therapeutic strategies to deal with fibrosis. Looking forward to pleasant, uninterrupted hours in the train to catch up on papers, paper reviewing and a miserably stalled grant application.

Mock Test Paper Series-I is now available for Students appearing in CA Foundation Course for the June 2024 Examinations. To access , login at ICAI BoS Mobile App or BoS Knowledge Portal: boslive.icai.org

Public Finance and Management (PFM) Special Issue Call for Papers: Symposium Issue – Application of Blockchain Technology in PFM. Learn more ➡️ ow.ly/e2TT50RmaIJ @PFM_Journal Deadline: April 30th, 2024

Delighted that this paper on well-being apps, creepiness, and AI is finally out in the world: dl.acm.org/doi/10.11… Lovely, as ever, to work with @choung_hyesun, @prabudavid, and Jaime Snyder

#ChinaAIWatch Chinese AI innovation identifies oesophageal cancer lesions at double rate of doctors’ assessment by eye: paper Yes, this is reality of AI development and application, vast majority of use cases civilian not military... www.scmp.com/news/ch…